Oral compounds and the liver
For anyone running a 17-alpha-alkylated oral, or reading a liver panel and trying to tell muscle from liver.
- 1The same chemistry (17-alpha-alkylation) that lets an oral survive the liver is what strains it.
- 2Raised ALT/AST alone is ambiguous. Hard training pushes them up too.
- 3A normal GGT with a raised CK points at muscle, not liver; rest before you test.
- 4Orals are kept to short blocks to limit cumulative strain and give the liver a recovery window.
High ALT/AST with a raised CK and a normal GGT points at the muscle you just trained, not steroid liver strain. Rest before you test.
The chemistry that lets an oral steroid survive the first pass through the liver is the same chemistry that strains it. Most oral anabolics are 17-alpha-alkylated: a methyl or ethyl group added at the 17th carbon slows the liver from breaking the molecule down, which is what makes it orally active, and that resistance to metabolism is inextricably tied to hepatotoxicity. This is why oral runs are conventionally kept short and why the liver is watched, not assumed to be fine. It is also why a raw liver panel is easy to misread in someone who trains hard.
Why 17-alpha-alkylation strains the liver
An unmodified steroid taken by mouth is largely destroyed by the liver before it reaches circulation. Adding an alkyl group at the 17-alpha position blocks that breakdown, so the compound survives and works orally. The cost is that the liver now processes a molecule engineered to resist processing, which shows up as strain on liver tissue.
- Raised aminotransferases (ALT and AST): the most common and earliest signal.
- Cholestasis: impaired bile flow, which can cause jaundice and itching.
- Peliosis hepatis: blood-filled cavities in the liver, associated with prolonged use.
- With long-term heavy use, benign and malignant liver tumours have been reported.
A few orally active compounds are not 17-alpha-alkylated (for example oral testosterone undecanoate, and non-steroidal agents), and carry a different liver profile. The concern above is specific to the 17-alpha-alkylated class, which covers most classic oral anabolics.
The training confound: muscle vs liver
ALT and AST are called "liver enzymes," but they are not liver-exclusive, skeletal muscle releases them too. Heavy resistance training, especially eccentric or novel work, raises both, sometimes substantially. A lifter can therefore see elevated ALT/AST and panic about their liver when the source is the muscle they just trained.
The way to separate the two is to look at markers muscle does not share. Creatine kinase (CK) rises with muscle damage but not liver injury. GGT is far more liver-specific. Classically, elevated aminotransferases together with a raised CK and a normal GGT point to muscle, not steroid liver damage.
| Marker | Rises with muscle work | Liver-specific |
|---|---|---|
| ALT / AST | Yes | No: shared with muscle |
| CK (creatine kinase) | Yes | No: muscle marker |
| GGT | No | Yes |
| Bilirubin | No | Yes (also cholestasis) |
Because training inflates ALT/AST, a panel drawn a day after heavy lifting overstates liver strain. Leaving a rest window before the draw makes the numbers reflect the liver, not the gym.
Why oral runs are kept short
The liver strain from 17-alpha-alkylated compounds is generally dose- and duration-dependent, and enzyme elevations often recede after the compound is stopped. That is the logic behind the convention of running orals for short blocks rather than continuously. It limits cumulative exposure and gives the liver a recovery window. Jaundice, dark urine, pale stools, right-upper-quadrant pain, or severe itching are signals to stop and seek care rather than push through.
This describes how oral compounds and the liver is done, and where it goes wrong. It is not a recommendation to do it, and it does not cover where to obtain anything. It is written on the assumption that the reader has already made that decision and would otherwise proceed without accurate information. Nothing here is medical advice: the safest version of every practice above still involves a clinician and lab work.
Where this applies
Related fundamentals
The panel that reflects what enhancement actually does to the body, when to draw it, and the thresholds that change decisions.
The symptoms that override "finish the cycle": the clot, liver, pancreatic, and infection red flags that mean stop and get medical help now.